AN
Annexon
ANNX·NASDAQS San Francisco CAFounded 2011150 employees
Small CapbiotechPublicNeurologyOphthalmology
Platform: Complement
Market Cap
$0.8B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ANNX)
Loading ANNX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Voxabrutinib | ANN-1950 | Phase 1/2 | 2 | EZH2 | CMLTTR Amyloidosis | ||
| Bemainavolisib | ANN-5609 | NDA/BLA | 1 | PRMT5 | CKDHS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)